Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells
about
Mechanisms of neuroblastoma cell growth inhibition by CARP-1 functional mimetics.Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer.Antitumor effects of a sirtuin inhibitor, tenovin-6, against gastric cancer cells via death receptor 5 up-regulation.Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo.Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers.Targeted approaches to childhood cancer: progress in drug discovery and development.Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model.The predictive value of ERCC1 and p53 for the effect of panobinostat and cisplatin combination treatment in NSCLC.Targeting histone deacetylases (HDACs) and Wee1 for treating high-risk neuroblastoma.The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells.Targeting of epigenetic regulators in neuroblastoma.Synergistic anticancer effect of panobinostat and topoisomerase inhibitors through ROS generation and intrinsic apoptotic pathway induction in cervical cancer cells.
P2860
Q33916362-54CD18CA-9DCF-4A1F-9EFC-59780722881DQ34808616-E44CEED7-A8B0-4410-8566-1FAFED97BEB7Q35208277-2AA90D34-E1FC-4485-A4D5-12316BE8D706Q35691776-B1516FF9-A373-49CF-8096-F632D368526FQ36843733-EA355A79-B358-49B9-BD33-985ECC1F592BQ37386051-A8CCCFB4-ABEC-4807-9D78-4852148C82A0Q38404462-4B1DA5C8-77AE-41B6-938E-341963EEB172Q38791113-AEA3AEF2-5BD7-4ACD-87A4-5EBD140C6859Q38878715-1F3B6A51-01AA-40BA-9B19-8C3EEDF3EE0CQ38948573-3BA9E229-F164-4B0E-B497-2F7C84EBA129Q48303460-CBC9049A-C450-4F1C-A2EA-543E040E79B5Q52560224-5B155D6D-B96C-46ED-82D6-4E2585E3496AQ52739228-E515BF9C-3CB8-4A8C-AA88-67ACE3E6BFAB
P2860
Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cells
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Panobinostat synergistically e ...... high-risk neuroblastoma cells
@ast
Panobinostat synergistically e ...... high-risk neuroblastoma cells
@en
Panobinostat synergistically e ...... high-risk neuroblastoma cells
@nl
type
label
Panobinostat synergistically e ...... high-risk neuroblastoma cells
@ast
Panobinostat synergistically e ...... high-risk neuroblastoma cells
@en
Panobinostat synergistically e ...... high-risk neuroblastoma cells
@nl
prefLabel
Panobinostat synergistically e ...... high-risk neuroblastoma cells
@ast
Panobinostat synergistically e ...... high-risk neuroblastoma cells
@en
Panobinostat synergistically e ...... high-risk neuroblastoma cells
@nl
P2093
P2860
P1433
P1476
Panobinostat synergistically e ...... high-risk neuroblastoma cells
@en
P2093
Holly Edwards
J Timothy Caldwell
Jeffrey W Taub
Steven A Buck
William Y Qing
Zhihong Wang
P2860
P304
P356
10.1371/JOURNAL.PONE.0076662
P407
P577
2013-01-01T00:00:00Z